ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
38
views
0
references
Top references
cited by
2
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,516
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Liraglutide and cardiovascular outcomes in Type 2 diabetes
Author(s):
S. Cohen
,
C Beckey
,
S. COHEN
Publication date:
2016
Journal:
N Engl J Med.
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
oa repository (via OAI-PMH title match)
oa repository (via OAI-PMH title match)
oa repository (via OAI-PMH title match)
oa repository (via OAI-PMH title match)
oa repository (via OAI-PMH title match)
oa repository (via OAI-PMH title match)
oa repository (via OAI-PMH title match)
Powered by
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cardiovascular Innovations and Applications
Author and article information
Journal
DOI::
10.1056/NEJMc1611289
PubMed ID::
27806226
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,516
Proportion de patients présentant soit un taux d’HbA1c < 7 %, soit une baisse d’au moins 1 % après 2ans de traitement par le liraglutide – Analyse post-hoc des résultats de l’étude EVIDENCE®
Authors:
J.F. Gautier
,
A Penfornis
,
G. Charpentier
…
GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide.
Authors:
Laszlo Hegedüs
,
Alan Moses
,
Milan Zdravkovic
…
Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial
Authors:
See all similar
Cited by
2
Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
Authors:
Nordin M. J. Hanssen
,
Michael Kraakman
,
Michelle C Flynn
…
Evaluation of large‐scale clinical trials on cardiovascular disease risk in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase 4 inhibitors and a new class of drugs
Authors:
Takeshi Kurose
,
Yoshiyuki Hamamoto
,
Yutaka Seino
See all cited by